Table 3.

Effect of Pregnancy Outcome on Plasma Glycocalyx Components

Variable	Normotensive (n=43)	GDM (n=10)	Late‐Onset PE (n=11)	Early Onset PE (n=11)
Gestational age, wk	39 (33–40)*	37 (33–39)*	38 (36–39)*	33 (30–34)
HSPG, pg/mL	1984 (1679–2618)*	1566 (1398–1839)*	3228 (2294–3697)	2952 (2177–3572)
HA, ng/mL	654 (585–719)*	611 (550–667)	754 (668–836)	757 (642–991)
SDC1, ng/mL	161 (70–1109)	124 (86–450)	125 (47–1872)	189 (81–365)

Data were skewed and are presented as median (interquartile range). Groups were compared with a Kruskal–Wallis test (Mann–Whitney post hoc test). One outlier was excluded. GDM indicates gestational diabetes mellitus; HA, hyaluronic acid; HSPG, heparan sulfate proteoglycans; PE, preeclampsia; SDC1, syndecan 1.

^* P<0.05 compared with early onset PE.